Neovasc to Present at the 38th Annual Canaccord Genuity Growth Conference
Published: Aug 06, 2018
VANCOUVER, Aug. 6, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that Fred Colen, President and Chief Executive Officer of Neovasc, is scheduled to present at the 38th Annual Canaccord Genuity Growth Conference on Wednesday, August 8th at 12:30 pm ET being held in Boston, Massachusetts.
A live audio webcast of the presentation will be available on the Investors page of Neovasc's website at www.neovasc.com.
About Neovasc Inc.
SOURCE Neovasc Inc.
Company Codes: NASDAQ-SMALL:NVCN, Toronto:NVCN